Zydus Cadila 3-dose COVID-19 Vaccine for Children may take Longer to be Approved

A vaccine against the coronavirus disease (Covid-19) for children being developed by Gujarat-based drug company Zydus Cadila may not be available soon as emergency approval from the country’s top drug regulator is likely to take a few more days.

• On July 1, the company had sought emergency use approval of ZyCoV-D, its DNA vaccine against Covid-19 for those aged 12 years and above, from the Drugs Controller General of India (DCGI).
• It had presented interim results from Phase-III clinical trials in over 28,000 volunteers. The study is said to have demonstrated safety and efficacy in the interim data.
• The data has shown that ZyCoV-D is safe for children in the age group of 12 to 18 years, said the company, which is planning to manufacture 100-120 million doses of the vaccine annually.

Also, read| Famous Janpath Market closed, Covid guidelines were being violated

Zyvox-D is a three-dose vaccine

• During the peak of the second wave of COVID-19 (in India), the study was conducted confirming the vaccine’s efficacy against new mutant strains, especially the delta variant,” Zydus Cadila said in a statement.
• The second indigenous jab after Bharat Biotech’s Covaxin, ZyCoV-D is a three-dose vaccine.
• According to Zydus Cadila, the three doses of ZyCoV-D are to be administered on day 0, day 28, and day 56.
• The company is also said to be working on a two-dose vaccine.
• The DCGI had granted Cadila Healthcare Limited permission to conduct human trials for ZyCoV-D back in July last year, when the company had said its vaccine will hit the markets by June 2021.

Once Zydus Cadila receives approval, ZyCoV-D would become the fifth anti-Covid vaccine authorized for use in India, after AstraZeneca and Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin, Sputnik V that is being developed by Russia’s Gamaleya Institute and Moderna.

For daily news updates related to finance, business and sports keep following our portal Daily News Capsule

Nikita Dhyani

Nikita Dhyani is a passionate writer. She basically writes on Health, Finance, and Politics related topics. She has explored many areas of interest and is being a part of the journalism industry.